Nelson Van Denburg & Campbell Wealth Management Group LLC Reduces Position in MetLife, Inc. (NYSE:MET)

Nelson Van Denburg & Campbell Wealth Management Group LLC reduced its stake in MetLife, Inc. (NYSE:MET) by 3.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 25,118 shares of the financial services provider’s stock after selling 979 shares during the period. Nelson Van Denburg & Campbell Wealth Management Group LLC’s holdings in MetLife were worth $1,300,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its stake in MetLife by 3.0% in the first quarter. Vanguard Group Inc. now owns 65,364,620 shares of the financial services provider’s stock valued at $3,452,559,000 after buying an additional 1,885,246 shares in the last quarter. Meiji Yasuda Asset Management Co Ltd. increased its stake in MetLife by 22.8% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 23,860 shares of the financial services provider’s stock valued at $1,260,000 after buying an additional 4,425 shares in the last quarter. Menta Capital LLC purchased a new stake in MetLife during the first quarter valued at about $721,000. Columbus Hill Capital Management L.P. boosted its position in MetLife by 5.1% in the first quarter. Columbus Hill Capital Management L.P. now owns 158,218 shares of the financial services provider’s stock valued at $8,357,000 after buying an additional 7,718 shares during the last quarter. Finally, Marshall Wace North America L.P. bought a new position in MetLife during the first quarter valued at approximately $884,000. 75.61% of the stock is owned by institutional investors.

Shares of MetLife, Inc. (NYSE:MET) traded up 0.15% during mid-day trading on Friday, reaching $47.02. 7,662,137 shares of the company’s stock traded hands. The company has a market cap of $49.98 billion, a price-to-earnings ratio of 553.18 and a beta of 1.46. The company has a 50 day moving average of $48.77 and a 200 day moving average of $47.24. MetLife, Inc. has a 12 month low of $35.72 and a 12 month high of $51.77.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.28 by $0.02. The firm had revenue of $17.39 billion for the quarter, compared to analyst estimates of $17.11 billion. MetLife had a return on equity of 8.51% and a net margin of 0.30%. The business’s quarterly revenue was up 2.5% compared to the same quarter last year. During the same period last year, the company earned $0.83 EPS. Analysts expect that MetLife, Inc. will post $4.88 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 13th. Stockholders of record on Monday, August 7th will be given a $0.40 dividend. The ex-dividend date is Thursday, August 3rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.40%. MetLife’s dividend payout ratio is currently 1,777.98%.

ILLEGAL ACTIVITY WARNING: This article was first posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.com-unik.info/2017/08/19/nelson-van-denburg-campbell-wealth-management-group-llc-decreases-position-in-metlife-inc-nysemet-updated-updated-updated.html.

Several equities analysts recently commented on the stock. BidaskClub upgraded shares of MetLife from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. Zacks Investment Research cut shares of MetLife from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Wells Fargo & Company restated a “buy” rating on shares of MetLife in a research note on Saturday, July 1st. Langen Mcalenn restated a “buy” rating on shares of MetLife in a research note on Wednesday. Finally, ValuEngine upgraded shares of MetLife from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 11th. Two analysts have rated the stock with a sell rating, six have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $59.17.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Institutional Ownership by Quarter for MetLife (NYSE:MET)

What are top analysts saying about MetLife Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MetLife Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit